egtazic acid has been researched along with amlodipine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrido, MD; Israel, A | 1 |
| Pop, E | 1 |
| Faverdin, C; Marche, P; Polidano, E; Yin, X | 1 |
| Bähr, M; Boretius, S; Diem, R; Fairless, R; Frahm, J; Gadjanski, I; Hochmeister, S; Knöferle, J; Lingor, P; Michaelis, T; Sättler, MB; Storch, MK; Sühs, KW; Williams, SK | 1 |
| Araki, E; Fukuda, K; Ishii, N; Kawada, T; Kim-Mitsuyama, S; Kinoshita, H; Matsumura, T; Miyamura, N; Motoshima, H; Nakao, S; Nishikawa, T; Senokuchi, T; Takeya, M; Tsutsumi, A | 1 |
5 other study(ies) available for egtazic acid and amlodipine
| Article | Year |
|---|---|
Endothelin-1 stimulates phosphoinositide hydrolysis in the rat pineal gland.
Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chelating Agents; Egtazic Acid; Endothelin-1; Enzyme Inhibitors; Inositol Phosphates; Intercellular Signaling Peptides and Proteins; Male; Neomycin; Peptides; Phosphatidylinositol Diacylglycerol-Lyase; Phosphatidylinositols; Pineal Gland; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Second Messenger Systems; Type C Phospholipases; Wasp Venoms | 1999 |
Trends in neuroprotection.
Topics: Aged; Amlodipine; Animals; Antiparkinson Agents; Apoptosis; Brain Diseases; Calcium Channel Blockers; Cannabinoids; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Dopamine Agents; Egtazic Acid; Eye Diseases; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Memantine; Mice; Multicenter Studies as Topic; Neuroprotective Agents; Optic Nerve Diseases; Pregnatrienes; Rats | 2002 |
Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2.
Topics: Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; ErbB Receptors; Isradipine; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Thrombin; Verapamil | 2005 |
Role of n-type voltage-dependent calcium channels in autoimmune optic neuritis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Amlodipine; Amyloid beta-Protein Precursor; Animals; Autoimmune Diseases; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cytokines; Disease Models, Animal; Drug Interactions; Ectodysplasins; Egtazic Acid; Excitatory Amino Acid Antagonists; Female; Glial Fibrillary Acidic Protein; Magnetic Resonance Imaging; Manganese; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neoplasm Proteins; omega-Conotoxin GVIA; Optic Nerve; Optic Neuritis; Quinoxalines; Rats; RNA-Binding Proteins | 2009 |
Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
Topics: Amlodipine; Animals; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Cardiovascular Agents; Cells, Cultured; Chelating Agents; Chemokine CCL2; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Flavonoids; Humans; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Nifedipine; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; RNA Interference; RNA, Messenger; Time Factors; Transfection | 2010 |